- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Better Results for Patients at Risk for CAD with High-Res Coronary CT Angiography
High resolution coronary CT angiography provides better results among patients at high risk for CAD than does standard resolution coronary angiography.
High resolution (HR) coronary CT angiography could be a useful tool in assessing patients at high risk for coronary artery disease (CAD), according to a study published in the journal Radiology.
Researchers from Italy performed a randomized study of 184 patients who were at high risk for CAD to evaluate the image quality, evaluability, diagnostic accuracy and radiation exposure of HR coronary CT angiography, compared with standard spatial resolution (SR). All patients underwent invasive coronary angiography (ICA) within seven days of undergoing SR coronary CT angiography (91 patients) or HR coronary CT angiography (93).
The results showed that there were advantages from the HR coronary CT angiographies compared with the SR coronary CT angiographies:
Higher specificity and accuracy were also seen in patient based analysis: HR coronary CT angiography specificity of 91 percent, compared with SR at 46 percent, and HR coronary CT angiography accuracy of 98 percent, compared with SR at 92 percent.
The authors concluded that these findings suggest “a potential use for this technology in patients at high risk for CAD.”
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
